|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| C07F 5/02 | (2006.01) | ||
| C07F 5/05 | (2006.01) |
| (11) | Number of the document | 4058453 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20821492.4 |
| Date of filing the European patent application | 2020-11-13 | |
| (97) | Date of publication of the European application | 2022-09-21 |
| (45) | Date of publication and mention of the grant of the patent | 2025-12-24 |
| (46) | Date of publication of the claims translation | 2026-03-10 |
| (86) | Number | PCT/US2020/060421 |
| Date | 2020-11-13 |
| (87) | Number | WO 2021/097212 |
| Date | 2021-05-20 |
| (30) | Number | Date | Country code |
| 201962935502 P | 2019-11-14 | US |
| (72) |
PARSONS, Andrew T. , US
BEAVER, Matthew , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pagerinta KRAS G12C inhibitoriaus junginio sintezė |
| IMPROVED SYNTHESIS OF KRAS G12C INHIBITOR COMPOUND |